Observational studyEuropean heart journal. Cardiovascular pharmacotherapy2025

Effectiveness and safety of rivaroxaban vs. apixaban in patients with atrial fibrillation and peripheral artery disease.

Loubna Dari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.